Rocket Lab's Record Quarter Sends Shares into Orbit
Rocket Lab reported Q3 revenue of $267.8M, up 73% YoY, beating estimates but posting a GAAP loss of $0.12 per share. Backlog grew 52% to $3.57B. Neutron rocket debut delayed to 2027, but 8 missions booked at higher prices. Q4 guidance: revenue $270M-$290M, adjusted EBITDA loss of $14M-$20M.
How this was made
The 30-second read
Why it matters
The earnings release introduces new quantitative data and forward guidance, making it a primary source of market‑moving information.
Market read
First‑time earnings disclosure for Rocket Lab with material numbers and guidance, likely to influence its stock and peers in the small‑sat launch space.
What to watch
Potential delays in Neutron and integration costs from Iridium acquisition may weigh on near‑term cash flow.
Background
Rocket Lab reported a record quarter with strong revenue growth but a GAAP loss, providing fresh guidance for Q4 and updates on its Iridium acquisition and Neutron program.
Ticker impact
Q3 earnings released with revenue $267.8M (+73% YoY) and GAAP loss $0.12/share; guidance for Q4 revenue $270-290M and adjusted EBITDA loss $14-20M.
likely modest pressure as market prices in loss and integration costs, but potential upside if guidance holds.
Numbers are fresh and material; investors will weigh revenue beat against loss and guidance.
Market effects
Highlights growing demand for small‑sat launch services and price‑raising environment in the space sector.
U.S. small‑cap aerospace stocks may see volatility as investors reassess exposure to launch‑service providers.
Signals broader trend of consolidation in satellite launch and payload markets.
Counterpoint
Despite the loss, the expanding backlog and higher launch prices could justify a longer‑term bullish stance.
Key entities
- CompanyRocket Lab
Aerospace manufacturer and launch service provider.
- CompanyIridium
Target of pending acquisition by Rocket Lab.
